Ozempic, Wegovy-maker hires lobbying firm to push for Medicare coverage
The blockbuster weight loss drugs’ access to a key market — older Americans — is limited, as Medicare is banned from covering weight loss drugs as part of the Part D program.
Today's Liberal News
By Megan R. Wilson
Ozempic, Wegovy-maker hires lobbying firm to push for Medicare coverage
The blockbuster weight loss drugs’ access to a key market — older Americans — is limited, as Medicare is banned from covering weight loss drugs as part of the Part D program.
Ozempic, Wegovy-maker hires lobbying firm to push for Medicare coverage
The blockbuster weight loss drugs’ access to a key market — older Americans — is limited, as Medicare is banned from covering weight loss drugs as part of the Part D program.
Ozempic, Wegovy-maker hires lobbying firm to push for Medicare coverage
The blockbuster weight loss drugs’ access to a key market — older Americans — is limited, as Medicare is banned from covering weight loss drugs as part of the Part D program.
Ozempic, Wegovy-maker hires lobbying firm to push for Medicare coverage
The blockbuster weight loss drugs’ access to a key market — older Americans — is limited, as Medicare is banned from covering weight loss drugs as part of the Part D program.
Ozempic, Wegovy-maker hires lobbying firm to push for Medicare coverage
The blockbuster weight loss drugs’ access to a key market — older Americans — is limited, as Medicare is banned from covering weight loss drugs as part of the Part D program.
Ozempic, Wegovy-maker hires lobbying firm to push for Medicare coverage
The blockbuster weight loss drugs’ access to a key market — older Americans — is limited, as Medicare is banned from covering weight loss drugs as part of the Part D program.
Merck sues HHS over drug negotiation, claims program ‘tantamount to extortion’
In its suit, the drug giant claims that Medicare negotiation program is unconstitutional
‘Not business as usual’: Health lobbyists brace for Bernie Sanders
Sanders’ well-chronicled antagonism toward lobbyists has some concerned they’ll be unable to blunt criticism of their clients’ profits or corporate executive salaries.
‘Not business as usual’: Health lobbyists brace for Bernie Sanders
Sanders’ well-chronicled antagonism toward lobbyists has some concerned they’ll be unable to blunt criticism of their clients’ profits or corporate executive salaries.
‘No-win situation’: Pharma trade CEO steps down after clashing with board
The departure of Michelle McMurry-Heath comes just as the Biden administration is poised to begin implementing key drug pricing provisions and the balance of power could shift in Congress.
‘No-win situation’: Pharma trade CEO steps down after clashing with board
The departure of Michelle McMurry-Heath comes just as the Biden administration is poised to begin implementing key drug pricing provisions and the balance of power could shift in Congress.
‘No-win situation’: Pharma trade CEO steps down after clashing with board
The departure of Michelle McMurry-Heath comes just as the Biden administration is poised to begin implementing key drug pricing provisions and the balance of power could shift in Congress.
‘No-win situation’: Pharma trade CEO steps down after clashing with board
The departure of Michelle McMurry-Heath comes just as the Biden administration is poised to begin implementing key drug pricing provisions and the balance of power could shift in Congress.
‘No-win situation’: Pharma trade CEO steps down after clashing with board
The departure of Michelle McMurry-Heath comes just as the Biden administration is poised to begin implementing key drug pricing provisions and the balance of power could shift in Congress.
‘No-win situation’: Pharma trade CEO steps down after clashing with board
The departure of Michelle McMurry-Heath comes just as the Biden administration is poised to begin implementing key drug pricing provisions and the balance of power could shift in Congress.
DaVita helped craft new bill to fix “loophole” left by Supreme Court ruling, documents show
Lawmakers introduced a measure mirroring a proposal written by one of the nation’s largest dialysis providers.
DaVita helped craft new bill to fix “loophole” left by Supreme Court ruling, documents show
Lawmakers introduced a measure mirroring a proposal written by one of the nation’s largest dialysis providers.
DaVita helped craft new bill to fix “loophole” left by Supreme Court ruling, documents show
Lawmakers introduced a measure mirroring a proposal written by one of the nation’s largest dialysis providers.
Pharma group leader says Dems who vote for reconciliation bill ‘won’t get a free pass’
PhRMA CEO Steve Ubl says the group is still fighting hard against the drug pricing provisions, but is making contingency plans — and promises — should reconciliation become law.
Pharma group leader says Dems who vote for reconciliation bill ‘won’t get a free pass’
PhRMA CEO Steve Ubl says the group is still fighting hard against the drug pricing provisions, but is making contingency plans — and promises — should reconciliation become law.
Pharma group leader says Dems who vote for reconciliation bill ‘won’t get a free pass’
PhRMA CEO Steve Ubl says the group is still fighting hard against the drug pricing provisions, but is making contingency plans — and promises — should reconciliation become law.
Pharma group leader says Dems who vote for reconciliation bill ‘won’t get a free pass’
PhRMA CEO Steve Ubl says the group is still fighting hard against the drug pricing provisions, but is making contingency plans — and promises — should reconciliation become law.
Drugmakers are waging a ‘Hail Mary’ campaign to sink reconciliation bill
The package would permit negotiation on drug pricing in Medicare and appears to have a path to passage.
Drugmakers are waging a ‘Hail Mary’ campaign to sink reconciliation bill
The package would permit negotiation on drug pricing in Medicare and appears to have a path to passage.
Drugmakers are waging a ‘Hail Mary’ campaign to sink reconciliation bill
The package would permit negotiation on drug pricing in Medicare and appears to have a path to passage.
Drugmakers are waging a ‘Hail Mary’ campaign to sink reconciliation bill
The package would permit negotiation on drug pricing in Medicare and appears to have a path to passage.
Drugmakers are waging a ‘Hail Mary’ campaign to sink reconciliation bill
The package would permit negotiation on drug pricing in Medicare and appears to have a path to passage.
Telehealth lobbyists fear abortion debate could erase wins
They are avoiding the fallout from the Roe decision to ensure eased rules are extended beyond the pandemic.
Telehealth lobbyists fear abortion debate could erase wins
They are avoiding the fallout from the Roe decision to ensure eased rules are extended beyond the pandemic.